A risk assessment report on 4-methylamphetamine was drawn up on the basis of Article 6 of Decision 2005/387/JHA by a special session of the extended Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction, and was subsequently received by the Commission on 29 November 2012.
Euroopa Narkootikumide ja Narkomaania Seirekeskuse laiendatud teaduskomitee koostas otsuse 2005/387/JSK artikli 6 kohaselt riskihindamisaruande 4-metamfetamiini kohta ja esitas selle seejärel 29. novembril 2012 komisjonile.